Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050422-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 26, 2026 |
| Document Date | Jan 22, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
15,000
Total Value
$279,712.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Finance | Common Stock | โ | Jan 22, 2026 | Exercise/Conversion | 2,497 | $10.42 | $26,018.74 | 15,462 | Direct | โ | View Details | |
SVP, Finance | Common Stock | โ | Jan 22, 2026 | Exercise/Conversion | 2,503 | $10.42 | $26,081.26 | 17,965 | Direct | โ | View Details | |
SVP, Finance | Common Stock | โ | Jan 22, 2026 | Sale | 5,000 | $45.52 | $227,612.00 | 12,965 | Direct | โ | View Details | |
SVP, Finance | Stock Option (Right to Buy) | Derivative | Jan 22, 2026 | Exercise/Conversion | 2,497 | $0.00 | $0.00 | 486 | Direct | โ | View Details | |
SVP, Finance | Stock Option (Right to Buy) | Derivative | Jan 22, 2026 | Exercise/Conversion | 2,503 | $0.00 | $0.00 | 7,869 | Direct | โ | View Details |